You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆瑞醫藥(600276.SH)漲超4% 孫飄揚卸任 職業經理人走到台前
格隆匯 01-17 11:13
格隆匯1月17日丨國內市值最高的藥企恆瑞醫藥(600276.SH)昨晚發佈人士變動公告,公司“靈魂人物”,同時也被稱為“醫藥一哥”的孫飄揚不再擔任公司董事長職務,轉任董事及戰略委員會主任委員,周雲曙接任為公司第八屆董事會董事長。

恆瑞醫藥(600276.SH)今日明顯上漲,現報90.6元,漲4.81%,暫成交25.5億元,最新總市值4004億元。該股在2019年累漲99.7%。
據悉,周雲曙2003年至今一直擔任恆瑞醫藥總經理一職,歷時17年,先後分管過研發、人力資源、企業運營等業務,並於2014年開始主抓銷售工作,而這期間,恆瑞醫藥的銷售業績實現了穩步提升。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account